Leaders of the three largest seed and chemical companies say it’s technologically possible to reduce farming’s environmental footprint while feeding a growing global population, but they worry policymakers and regulators will stand in the way.
President Donald Trump’s claim that China is willing to address “agricultural structural issues” in a trade deal has the U.S. ag sector excited that real change may be coming to the U.S-China trading relationship beyond just increased commodity sales.
The United States and China have agreed to a tentative trade deal that addresses biotechnology and other key agricultural issues while substantially boosting U.S. farm exports, President Donald Trump said Friday.
Trump administration officials say they are committed to reducing regulatory barriers to agricultural biotechnology as part of a larger strategy to promote the development of a "bioeconomy" based on far-reaching scientific innovations that could revolutionize medicine, nutrition and manufacturing as well as farming.
The CEO of seed and chemical giant Corteva Agriscience believes farmers must play a major role in reducing greenhouse gas emissions and says he's working with other companies as well as academics and non-governmental organizations to address the climate issue.
Crop developers say USDA’s effort to streamline its regulation of biotech crops will still slow the commercialization of many gene-edited products, but groups representing grain traders, food processors and restaurant chains are slamming the department's proposal, claiming it could lead to trade disruptions and undermine consumer confidence.
All three of the federal agencies charged with regulating bioengineered plants and animals are looking at ways of streamlining regulations and smoothing the path to commercialization for gene-edited traits.
Africa’s uneasy history with agricultural biotechnology can be summed up by what’s growing, and not growing, on a small research farm in central Malawi, one of the poorest and most food-insecure countries on the planet.
Former Sen. Richard Lugar, an Indiana Republican who won admirers from both political parties during a 36-year Senate career, died Sunday from complications of a chronic neurological disorder, according to the nonprofit Lugar Center, which he had founded.